Todas as matérias desta seção, das mais recentes às mais antigas — página 268 de 371.
Civeo (NYSE:CVEO) reported a significant improvement in its quarterly bottom line and a jump in cash flow, as aggressive cost-reduction efforts in Canada and a strategic expansion in Australia began to pay off.
Thor Industries (NYSE:THO) reported a return to profitability in its fiscal second quarter, bolstered by strong motorized RV demand, while simultaneously moving to dismantle its long-standing decentralized business model in North America.
Hycroft Mining Holding (NASDAQ:HYMC) revealed a substantial expansion of its precious metals deposit on Tuesday, coupled with a strengthened liquidity position that places the developer among the few debt-free juniors in the sector.
Esperion Therapeutics (NASDAQ:ESPR) moved to significantly broaden its cardiovascular portfolio on Tuesday, announcing a deal to acquire privately held Corstasis Therapeutics and its first-of-its-kind nasal spray for heart failure-related edema.
Flowco Holdings completed its acquisition of Valiant Artificial Lift Solutions on Tuesday, a $200 million move that significantly broadens its technology portfolio in the high-stakes Permian Basin.
Greenwich LifeSciences (NASDAQ:GLSI) surged ahead in its clinical timeline on Tuesday, reporting a significant acceleration in patient recruitment for its pivotal Phase III breast cancer study.
Lithia & Driveway (NYSE:LAD) continued its aggressive expansion into high-growth U.S. markets on Tuesday, announcing the acquisition of two dealerships that bolster its presence in both the luxury and volume segments.
On Holding reported a double-digit jump in fourth-quarter sales, fueled by an explosive performance in Asia-Pacific and record-high gross margins, even as a decline in net income underscored the costs of its rapid global scaling.
WeRide (NASDAQ:WRD), the Guangzhou-based autonomous driving unicorn, has officially halted its robotaxi fleet in Dubai.
Amazon Web Services (AWS) disclosed on Tuesday that drone strikes directly hit two of its facilities in the United Arab Emirates.
Precision BioSciences (NASDAQ:DTIL) announced Monday that it has achieved a $7.5 million clinical milestone under its licensing agreement with TG Therapeutics (NASDAQ:TGTX).
GT Biopharma (NASDAQ:GTBP) reported fiscal 2025 results on Monday, detailing a significant pivot toward its advanced camelid nanobody platform.
Astrana Health (NASDAQ:ASTH) delivered a year of explosive scale in 2025, according to financial results released Monday, with total revenue reaching $3.18 billion.
AAON (NASDAQ:AAON) reported fourth-quarter net income of $32 million on Monday, falling short of Wall Street expectations as the company absorbed significant costs related to its rapid capacity expansion.
Takeda (NYSE:TAK) and Protagonist Therapeutics (NASDAQ:PTGX) secured a major regulatory milestone on Monday as the U.S. Food and Drug Administration (FDA) granted Priority Review to rusfertide, an investigational treatment for polycythemia vera (PV).
Venture Global (NYSE:VG) and Trafigura announced a new, binding liquefied natural gas (LNG) supply agreement on Monday, marking a strategic shift toward mid-term contracting for the Arlington-based energy producer.
Alaunos Therapeutics (NASDAQ:TCRT) released proof-of-concept data from two separate diet-induced obesity (DIO) mouse studies on Monday, marking a strategic pivot toward non-hormonal metabolic treatments.
Ocugen (NASDAQ:OCGN) announced Monday that it has completed patient enrollment for its pivotal Phase 3 liMeliGhT clinical trial, evaluating OCU400 for the treatment of retinitis pigmentosa (RP).
Pharvaris (NASDAQ:PHVS) dominated the clinical spotlight at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2026 meeting on Monday, unveiling full data from its RAPIDe-3 and CHAPTER-1 trials.
Highway Holdings (NASDAQ:HIHO), a Hong Kong-based manufacturer of precision metal components and provider of contract manufacturing services, on Monday reported financial results for its third quarter and nine-month period ended December 31, 2025.
The Hain Celestial Group (NASDAQ:HAIN) finalized a major structural overhaul on Monday with the completed sale of its North American snacks portfolio to Snackruptors.
StealthGas (NASDAQ:GASS) delivered a strong financial performance for the fourth quarter and full year 2025, reporting a net income of $12.8 million for the final three months of the year.
Sionna Therapeutics (NASDAQ:SION) entered 2026 with a substantial financial cushion, reporting $310.3 million in cash, cash equivalents, and marketable securities as of December 31, 2025.
HBT Financial (NASDAQ:HBT), the holding company for Heartland Bank and Trust Company, announced Monday that it has successfully completed its merger with CNB Bank Shares.
